share_log

USD 239.83 mn growth in Extracorporeal Membrane Oxygenation Machines Market | Evolving Opportunities with ALung Technologies Inc & Eurosets Srl | 17000+ Technavio Reports

USD 239.83 mn growth in Extracorporeal Membrane Oxygenation Machines Market | Evolving Opportunities with ALung Technologies Inc & Eurosets Srl | 17000+ Technavio Reports

体外膜氧合器市场增长239.83美元|阿尔隆技术公司和Euroset Srl的发展机遇|17000+Technavio报告
PR Newswire ·  2021/11/29 17:16

NEW YORK, Nov. 29, 2021 /PRNewswire/ -- Technavio's latest offering, the Extracorporeal Membrane Oxygenation Machines Market report provides a detailed analysis of the competitive scenario and the market growth across various regions. The extracorporeal membrane oxygenation machines market value is expected to grow by USD 239.83 million, progressing at a CAGR of 10.27% as per the latest report by Technavio.

纽约2021年11月29日/美通社/--Technavio的最新产品,体外膜氧合器市场报告详细分析了各地区的竞争形势和市场增长。预计体外膜氧合器市场价值将增长2.393亿美元,以最快的速度前进复合年增长率为10.27%根据Technavio的最新报道。

For more insights on the Extracorporeal Membrane Oxygenation Machines Market - Download a free sample now!

有关体外膜氧合器市场的更多信息-立即下载免费样本!

Attractive Opportunities in Extracorporeal Membrane Oxygenation Machines Market by Modality and Geography - Forecast and Analysis 2021-2025
按形态和地理划分的体外膜氧合机市场机遇--2021-2025年预测与分析

38% of the market's growth will originate from North America. US and Canada are the key markets for extracorporeal membrane oxygenation machines in the region. The rising number of new product launches will facilitate the extracorporeal membrane oxygenation machines market growth in North America 

38%的市场增长将来自 北美。美国和加拿大是该地区体外膜氧合器的主要市场。不断增加的新产品发布将促进体外膜氧合器在北美的市场增长

Market Dynamics

市场动态

Factors such as the increasing incidence of respiratory and heart failure and the growing number of transplant procedures will drive the growth of the Extracorporeal Membrane Oxygenation Machines Market. However, high costs associated with cardiac and respiratory procedures might hamper the market growth.

一些因素,如呼吸和心力衰竭的发病率不断增加,移植手术的数量也在不断增加将推动体外膜氧合器市场的增长。然而,与心脏和呼吸手术相关的高成本可能会阻碍市场增长。

Company Profiles

公司概况

The extracorporeal membrane oxygenation machines market is fragmented and the vendors are deploying various organic and inorganic growth strategies to compete in the market. The extracorporeal membrane oxygenation machines market report includes information on the product launches, sustainability, and prospects of leading vendors including ALung Technologies Inc., Eurosets Srl, Fresenius Medical Care AG, and Co. KGaA, Getinge AB, LivaNova Plc, Medtronic Plc, MicroPort Scientific Corp., Nipro Corp., OriGen Biomedical Inc., and Terumo Corp.

体外膜氧合器市场支离破碎供应商正在部署各种有机和无机增长战略,以在市场上竞争。体外膜氧合器市场报告包括有关领先供应商的产品推出、可持续性和前景的信息,这些供应商包括ALung Technologies Inc.、Eurosets Srl、Fresenius Medical Care AG和Co.KGaA、Getinger AB、LivaNova Plc、美敦力、MicroPort Science Corp.、Nipro Corp.、Origen Biomedical Inc.和Terumo Corp.

Few Companies with Key Offerings

很少有公司提供关键产品

  • ALung Technologies Inc. - The company offers extracorporeal membrane oxygenation machines that provide ultra low flow, venovenous extracorporeal carbon dioxide removal using a single, 15.5 French dual lumen catheter inserted percutaneously in the femoral or jugular vein and removes 25 to 50 percent of basal metabolic CO2 production at circuit blood flows of 350 to 550 mL per minute, under the brand name of Hemolung RAS.
  • Eurosets Srl - The company offers extracorporeal membrane oxygenation machines that are designed to focus on optimal gas microemboli management and of its full coating with phosphorylcholine to work in a unique range of volumes, from less than 250 ml up to 2000 ml., under the brand name of Eurosets.
  • Fresenius Medical Care AG and Co - The company offers extracorporeal membrane oxygenation machines that enable gas exchange and circulation, respectively, when standard treatment fails thus providing clinicians time to treat patients, under the brand name of Xenios.
  • ALung Technologies Inc.-该公司提供的体外膜氧合器可提供超低流量、静脉-静脉体外二氧化碳清除服务,该设备使用一根15.5法国双腔导管经皮插入股静脉或颈静脉,在循环血流量为350-550毫升/分钟(品牌为Hemolung RAS)的情况下,可清除25%-50%的基础代谢性二氧化碳产生量。
  • Euroset Srl-该公司提供体外膜氧合器,其设计重点是优化气体微栓子的治疗,并用磷酰胆碱进行全涂层,以Eurosets的品牌在不到250毫升到2000毫升的独特体积范围内工作。这款机器的设计重点是优化气体微栓子的治疗,并用磷酰胆碱进行全涂层,使其在不到250毫升到2000毫升的独特体积范围内工作。
  • 费森尤斯医疗保健股份公司(Fresenius Medical Care AG)该公司提供Xenios品牌的体外膜氧合器,当标准治疗失败时,该机器可以分别实现气体交换和循环,从而为临床医生提供治疗患者的时间。

Competitive Analysis

竞争分析

The competitive scenario provided in the extracorporeal membrane oxygenation machines market report analyzes, evaluates, and positions companies based on various performance indicators. Some of the factors considered for this analysis include the financial performance of companies over the past few years, growth strategies, product innovations, new product launches, investments, growth in market share, etc.

体外膜氧合器市场报告中提供的竞争情景基于各种绩效指标对公司进行分析、评估和定位。这项分析考虑的一些因素包括公司过去几年的财务表现、增长战略、产品创新、新产品的推出、投资、市场份额的增长等。

Market Segmentation

市场细分

  • By Modality, the market is classified into  Veno-venous and Veno-arterial. The extracorporeal membrane oxygenation machines' market share growth by the Veno-venous segment has been significant. 
  • By Geography, the market is classified as North America, Europe, Asia, and ROW. North America will have the largest share of the market.
  • 根据形态,市场分为静脉-静脉和静脉-动脉。体外膜氧合器市场占有率的增长静脉-静脉段意义重大。
  • 根据地理位置,该市场被分类为北美, 欧洲, 亚洲,和划船。北美将拥有最大的市场份额。

Related Reports -
Neurodiagnostic and Monitoring Devices -The neurodiagnostic and monitoring devices market size in the US has the potential to grow by USD 443.81 million during 2020-2024.Download a free sample now!

相关报道-
神经诊断和监测设备-2020-2024年,美国的神经诊断和监测设备市场规模有可能增长4.4381亿美元。立即下载免费样本!

Chemiluminescence Immunoassay Analyzers Market -The chemiluminescence immunoassay (CLIA) analyzers market share is expected to increase by USD 3.24 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 10.32%. Download a free sample now!

化学发光免疫分析仪市场-从2021年到2026年,化学发光免疫分析(CLIA)分析仪的市场份额预计将增加32.4亿美元,市场增长势头将以10.32%的复合年增长率加速。立即下载免费样本!

Extracorporeal Membrane Oxygenation Machines Market Scope

Report Coverage

Details

Page number

120

Base year

2020

Forecast period

2021-2025

Growth momentum & CAGR

Accelerate at a CAGR of 10.27%

Market growth 2021-2025

USD 239.83 million

Market structure

Fragmented

YoY growth (%)

8.87

Regional analysis

North America, Europe, Asia, and ROW

Performing market contribution

North America at 38%

Key consumer countries

US, Germany, UK, Canada, China, and France

Competitive landscape

Leading companies, competitive strategies, consumer engagement scope

Companies profiled

ALung Technologies Inc., Eurosets Srl, Fresenius Medical Care AG and Co. KGaA, Getinge AB, LivaNova Plc, Medtronic Plc, MicroPort Scientific Corp., Nipro Corp., OriGen Biomedical Inc., and Terumo Corp.

Market Dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, market condition analysis for the forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

体外膜氧合器的市场范围

报告覆盖范围

细节

页码

120

基准年

2020

预测期

2021-2025

增长动能与复合年增长率

以10.27%的复合年均增长率加速

2021-2025年市场增长

2.393亿美元

市场结构

支离破碎

同比增长(%)

8.87

区域分析

北美、欧洲、亚洲和ROW

表演市场贡献

北美为38%

主要消费国

美国、德国、英国、加拿大、中国和法国

竞争格局

领先公司、竞争战略、消费者参与范围

公司概况

阿隆技术公司、Eurosets Srl公司、费森尤斯医疗保健股份公司和KGaA公司、Getinger AB公司、LivaNova公司、美敦力公司、MicroPort科学公司、Nipro公司、Origen Biomedical公司和Terumo公司。

市场动态

母市场分析,市场增长诱因和障碍,快增长和慢增长细分市场分析,新冠肺炎影响和未来消费者动态,预测期市场状况分析

定制权限

如果我们的报告没有包括您正在寻找的数据,您可以联系我们的分析师并定制细分市场。

About Us

关于我们

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Technavio是一家全球领先的技术研究和咨询公司。他们的研究和分析侧重于新兴市场趋势,并提供了可操作的见解,帮助企业识别市场机会并制定有效的战略,以优化其市场地位。Technavio的报告库拥有500多名专业分析师,由17000多份报告组成,并在不断统计,涵盖了横跨50个国家和地区的800项技术。他们的客户群包括各种规模的企业,其中包括100多家财富500强公司。不断增长的客户基础依赖于Technavio的全面覆盖、广泛的研究和可操作的市场洞察力,以确定现有和潜在市场中的机会,并评估它们在不断变化的市场情景中的竞争地位。

Contact

联系人

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]Website: www.technavio.com/

技术研究
杰西·迈达
媒体与营销主管
美国:+1 844 364 1100
英国:+44 203 893 3200
电子邮件:[受电子邮件保护]网站:Www.Technavio.com/

SOURCE Technavio

来源技术

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发